Black Diamond Therapeutics (BDTX) Depreciation and Depletion (2019 - 2021)
Historic Depreciation and Depletion for Black Diamond Therapeutics (BDTX) over the last 3 years, with Q4 2021 value amounting to $123000.0.
- Black Diamond Therapeutics' Depreciation and Depletion rose 72000.0% to $123000.0 in Q4 2021 from the same period last year, while for Dec 2021 it was $205000.0, marking a year-over-year increase of 29423.08%. This contributed to the annual value of $343000.0 for FY2024, which is 2151.03% down from last year.
- According to the latest figures from Q4 2021, Black Diamond Therapeutics' Depreciation and Depletion is $123000.0, which was up 72000.0% from $43000.0 recorded in Q3 2021.
- Over the past 5 years, Black Diamond Therapeutics' Depreciation and Depletion peaked at $123000.0 during Q4 2021, and registered a low of $9000.0 during Q4 2019.
- In the last 3 years, Black Diamond Therapeutics' Depreciation and Depletion had a median value of $13500.0 in 2019 and averaged $25333.3.
- Per our database at Business Quant, Black Diamond Therapeutics' Depreciation and Depletion crashed by 1666.67% in 2020 and then skyrocketed by 72000.0% in 2021.
- Over the past 3 years, Black Diamond Therapeutics' Depreciation and Depletion (Quarter) stood at $9000.0 in 2019, then soared by 66.67% to $15000.0 in 2020, then soared by 720.0% to $123000.0 in 2021.
- Its Depreciation and Depletion was $123000.0 in Q4 2021, compared to $43000.0 in Q3 2021 and $20000.0 in Q2 2021.